''On consolidated basis
Quarter ended June 2025 compared with Quarter ended June 2024.
Net sales (including other operating income) of Dr Lal Pathlabs has increased 11.28% to Rs 669.8 crore. Operating profit margin has jumped from 28.24% to 28.71%, leading to 13.12% rise in operating profit to Rs 192.30 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 19.84% to 19.24%. Employee cost increased from 19.37% to 19.75%. Other expenses fell from 32.55% to 32.29%. Selling and administration expenses fell from 13.91% to 13.77%.
Other income rose 36.41% to Rs 28.1 crore. PBIDT rose 15.63% to Rs 220.4 crore. Provision for interest fell 21.67% to Rs 4.7 crore.
PBDT rose 16.85% to Rs 215.7 crore. Provision for depreciation fell 0.29% to Rs 34.6 crore.
Profit before tax grew 20.81% to Rs 1...
Pleaselogin & subscribe to view the full report.
More Reports
|
|